Obesity is increasingly recognized as a chronic, relapsing disease rather than a temporary condition or lifestyle choice
Dose increases can help, but theyre not guaranteed to restart weight loss
That said, it seems like a company with pretty much endless funds that is putting together a trial comparing dose differences, could create a trial with sufficient statistical power to accurately compare the dose differences
Who should not use tirzepatide Personal or family history of medullary thyroid carcinoma (MTC) or MEN 2 Boxed warning
Anyone over thirty with a BMI of 30 or above, or with a BMI of 27, along with weight-related health problems such as hypertension or type two diabetes, can benefit from this medication
While some initial GI side effects like nausea may start to improve, you will likely notice more pronounced appetite shifts